Alliance Medical Group 15-valent Pneumococcal conjugate vaccine (1 dose)

Alliance Medical Group 15-valent Pneumococcal conjugate vaccine (1 dose)

Pneumonia is the second leading cause of death in Hong Kong, with a mortality rate of up to 30-47% for infections caused by serotype 3 pneumococcus!

Pneumococcus can cause various diseases, including otitis media and pneumonia, as well as invasive pneumococcal diseases such as meningitis when it invades the brain, or sepsis and bacteremia when it invades the blood. These diseases can be severe and even fatal, with serotype 3 being considered the number one killer of invasive pneumococcal disease. From 2016 to 2020, nearly 70% of invasive pneumonia diseases were caused by serotype 3 among the group of infants and children in Hong Kong.

- Precisely targets and enhances protection against Hong Kong's serotype 3 pneumococcus;
- Prevents 15 serotypes of pneumococcus (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F, 33F);
- Unique technology induces a stronger immune response, particularly against serotype 3 pneumococcus, which is 60% more effective than existing vaccines;
- Approved for use by the US FDA and the European Union.

Recommend For:

• Individuals aged 6 weeks or above;
• Elderly;
• High-risk individuals (such as those who have suffered from invasive pneumococcal disease, diabetes, chronic heart disease, lung disease, liver disease, or immunocompromised, etc.);

If you have been vaccinated with a 13-valent Pneumococcal Conjugate Vaccine or Pneumovax 23 Vaccine, you can receive a 15-Valent Pneumococcal Conjugate Vaccine one year apart. In addition, it is also recommended to consult your family doctor first.

*If it is considered as inapproriate to get vaccinated, HKD300 will be charged for Dr Consultation. The remaining amount shall be returned. health.ESDlife and Alliance Medical Group have sole discretion to make the final decision.